Cargando…
Prostaglandin E(2) acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro
Intermittent PTH is the major anabolic therapy for osteoporosis while continuous PTH causes bone loss. PTH acts on the osteoblast (OB) lineage to regulate bone resorption and formation. PTH also induces cyclooxygenase-2 (COX-2), producing prostaglandin E(2) (PGE(2)) that can act on both OBs and oste...
Autores principales: | Choudhary, Shilpa, Blackwell, Katherine, Voznesensky, Olga, Roy, Abhijit Deb, Pilbeam, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073290/ https://www.ncbi.nlm.nih.gov/pubmed/23639875 http://dx.doi.org/10.1016/j.bone.2013.04.017 |
Ejemplares similares
-
Optogenetic activation of Plexin-B1 reveals contact repulsion between osteoclasts and osteoblasts
por: Deb Roy, Abhijit, et al.
Publicado: (2017) -
Cyclooxygenase-2 Suppresses the Anabolic Response to PTH Infusion in Mice
por: Choudhary, Shilpa, et al.
Publicado: (2015) -
Parathyroid Hormone Induction of Cyclooxygenase-2 in Murine Osteoblasts: Role of the Calcium-Calcineurin-NFAT Pathway
por: Huang, Hechang, et al.
Publicado: (2010) -
Null mutation for Macrophage Migration Inhibitory Factor (MIF) is associated with less aggressive bladder cancer in mice
por: Taylor, John A, et al.
Publicado: (2007) -
Effects of PTH on osteoblast bioenergetics in response to glucose
por: DeMambro, Victoria E., et al.
Publicado: (2023)